UGT2B4 | UDP glucuronosyltransferase 2 family, polypeptide B4 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ASGR2 | Asialoglycoprotein receptor 2 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
SLC27A5 | Solute carrier family 27 (fatty acid transporter), member 5 | Enzymes Predicted membrane proteins Transporters
| | | | | Tissue enriched |
BAAT | Bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enriched |
HSD17B6 | Hydroxysteroid (17-beta) dehydrogenase 6 | Enzymes
| | | | | Tissue enriched |
TF | Transferrin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PON3 | Paraoxonase 3 | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINA1 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADH4 | Alcohol dehydrogenase 4 (class II), pi polypeptide | Enzymes Plasma proteins
| | | | | Tissue enriched |
HGFAC | HGF activator | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
LRG1 | Leucine-rich alpha-2-glycoprotein 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PROC | Protein C (inactivator of coagulation factors Va and VIIIa) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TFR2 | Transferrin receptor 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
RBP4 | Retinol binding protein 4, plasma | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TTC36 | Tetratricopeptide repeat domain 36 | | | | | | Tissue enriched |
ANGPTL3 | Angiopoietin-like 3 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFB | Complement factor B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CYP2C9 | Cytochrome P450, family 2, subfamily C, polypeptide 9 | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
PLG | Plasminogen | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
SERPINA3 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TTR | Transthyretin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACSM5 | Acyl-CoA synthetase medium-chain family member 5 | Enzymes Mitochondrial proteins
| | | | | Tissue enriched |
C3 | Complement component 3 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C4BPA | Complement component 4 binding protein, alpha | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
C6 | Complement component 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
NADK2 | NAD kinase 2, mitochondrial | Enzymes
| | | | | Tissue enriched |
SLC2A2 | Solute carrier family 2 (facilitated glucose transporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |